Matches in Nanopublications for { ?s ?p "[Although YC-1 was originally developed as a potential therapeutic agent for thrombosis and hypertension, recent studies demonstrated that YC-1 suppressed HIF-1 activity and vascular endothelial growth factor expression in cancer cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 2 of
2
with 100 items per page.
- NP308189.RAD3ZDXOVsaxIe98TTM-SvF4HGwPiz138UF0f1tKI2w_I130_assertion description "[Although YC-1 was originally developed as a potential therapeutic agent for thrombosis and hypertension, recent studies demonstrated that YC-1 suppressed HIF-1 activity and vascular endothelial growth factor expression in cancer cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP308189.RAD3ZDXOVsaxIe98TTM-SvF4HGwPiz138UF0f1tKI2w_I130_provenance.
- NP612029.RAPPo77wAeYA_tJii2AfZ3xxN05dlxYtv_JE8k3PUDN5E130_assertion description "[Although YC-1 was originally developed as a potential therapeutic agent for thrombosis and hypertension, recent studies demonstrated that YC-1 suppressed HIF-1 activity and vascular endothelial growth factor expression in cancer cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP612029.RAPPo77wAeYA_tJii2AfZ3xxN05dlxYtv_JE8k3PUDN5E130_provenance.